Russell Barton
Chief Operating Officer at ACUMEN PHARMACEUTICALS, INC.
Net worth: 284 789 $ as of 30/05/2024
Russell Barton active positions
| Companies | Position | Start | End |
|---|---|---|---|
| ACUMEN PHARMACEUTICALS, INC. | Chief Operating Officer | 31/03/2019 | - |
AgeneBio, Inc.
 AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Chief Tech/Sci/R&D Officer | 30/09/2019 | - |
| Pharma Sagacity Consulting LLC | President | 31/12/2017 | - |
Career history of Russell Barton
Former positions of Russell Barton
| Companies | Position | Start | End |
|---|---|---|---|
| ELI LILLY AND COMPANY | Chief Operating Officer | - | - |
Training of Russell Barton
| Illinois State University | Undergraduate Degree |
| Purdue University | Graduate Degree |
Statistics
International
| United States | 7 |
Operational
| Chief Operating Officer | 2 |
| Undergraduate Degree | 1 |
| Graduate Degree | 1 |
Sectoral
| Health Technology | 4 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| ACUMEN PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
AgeneBio, Inc.
AgeneBio, Inc. BiotechnologyHealth Technology AgeneBio, Inc. develops an innovative therapeutics for unserved patients afflicted with neurological and psychiatric diseases to preserve and restore brain function. It research focused on cognitive neuroscience and the neurobiology of the aging brain with most advanced clinical program targets amnestic mild cognitive impairment (aMCI), the symptomatic, pre-dementia stage of Alzheimer’s. The company was founded by Michela Gallagher in 2008 and is headquartered in Baltimore, MD. | Health Technology |
| Pharma Sagacity Consulting LLC |
- Stock Market
- Insiders
- Russell Barton
- Experience
